InvestmentTechnology
Ardan Equity and GI Partners Invest in Clinical ink
The co-control investment gives the company capital to scale its technology platform globally and pursue opportunities connecting clinical trials with technology-enabled patient care.
- Target
- Clinical ink
- Sponsors
- Ardan Equity, GI Partners
- Source
- citybiz.co